From the Journals

Don't rule out liver transplant grafts from octogenarians


 

FROM DIGESTIVE AND LIVER DISEASE

Donors aged 80 years or older are not necessarily inferior for a liver transplantation (LT) graft, compared with young ideal donors (aged 18-39 years), according to an analysis of the perioperative LT period.

While “the potential risks and benefits associated with the use of livers from octogenarian donors must be closely weighed, with careful donor evaluation, selective donor-to-recipient matching and skilled perioperative care, octogenarian grafts do not affect the short-term course of patients undergoing LT,” concluded Gianni Biancofiore, MD, of Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy, and his coauthors (Dig Liver Dis. 2017. doi: 10.1016/j.dld.2017.01.149).

Wavebreakmedia Ltd/ThinkStockPhotos.com
The authors reviewed a database of all LT procedures performed at their facility from 2001 to 2014. Of the procedures, 179 patients received a graft from a donor aged 18-39 years, while 167 patients received a graft from a donor aged 80 years or older.

Perioperative differences were insubstantial in terms of cardiovascular complications (P = .2), respiratory complications (P = 1.0), coagulopathy (P = .5), and incidence of perfusion syndrome (P = .3). Median ICU length of stay of the two groups was identical (P = .4). No differences in terms of death or retransplant were observed during the ICU stay.

“Accordingly, anesthesiologists and intensivists should not label liver allografts from donors aged 80 years [or older] as ‘unusable’ or ‘high risk’ ” based on age alone, the authors concluded.

The authors declared no sources of funding and no conflicts of interest.

Recommended Reading

VIDEO: EVLP may extend lung preservation, quality for transplants
MDedge Surgery
Antibiotic susceptibility differs in transplant recipients
MDedge Surgery
Survival shorter in extended-criteria lung recipients
MDedge Surgery
Nearly half of patients readmitted after liver transplant
MDedge Surgery
Frailty stratifies pediatric liver disease severity
MDedge Surgery
Selected liver-transplant patients thrive off immunosuppression
MDedge Surgery
Liver transplant waits shorter with DAAs
MDedge Surgery
Therapeutic alternative to liver transplantation could be on horizon in NASH
MDedge Surgery
Fragmented readmission after liver transplant linked to adverse outcomes
MDedge Surgery
Skin cancer a concern in pediatric solid organ transplant recipients
MDedge Surgery